Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis.
Ji-Lin LiShu-Han LinHong-Qiu ChenLi-Sheng LiangXian-Wei MoHao LaiJie ZhangJing XuBing-Qian GaoYan FengYuan LinPublished in: BMC clinical pathology (2019)
Our studies revealed that EGFR and HER2 are highly expressed in the primary tumours and metastases of CRC patients with ovarian metastases. HER2 positivity may be a negative prognostic predictor in patients with ovarian metastases.